Anesthesia Drugs Market Size

  • Report ID: 5842
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Anesthesia Drugs Market Size

Anesthesia Drugs Market size was over USD 7.12 billion in 2024 and is poised to exceed USD 11.56 billion by 2037, growing at over 3.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of anesthesia drugs is evaluated at USD 7.34 billion. The primary driver of the anesthetic drugs market expansion is the increasing number of surgical procedures performed worldwide. Over 310 million critical medical procedures are performed annually worldwide, with 40–50 million occurring in the US and 20 million in Europe.

In addition, both developed and developing countries are seeing increases in healthcare costs. In developing countries, underuse of public health care is a very common occurrence. Nonetheless, improving the healthcare infrastructure in underdeveloped countries has received more attention recently. In addition to building new healthcare facilities and renovating old ones, infrastructure for human capital development and training has been increased. Due to improved access to healthcare services and growing awareness of the benefits of timely surgical treatments, the number of surgeries performed globally has also increased.


Anesthesia Drugs Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5842
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of anesthesia drugs is evaluated at USD 7.34 billion.

The anesthesia drugs market size was over USD 7.12 billion in 2024 and is poised to exceed USD 11.56 billion by 2037, growing at over 3.8% CAGR during the forecast period i.e., between 2025-2037. The market growth is impelled by increasing number of surgical procedures performed worldwide.

North America industry is poised to dominate majority revenue share of 33% by 2037, due to rising number of people suffering from chronic illnesses in the region.

The major players in the market include Hikma Pharmaceuticals Plc, Abbott Laboratories, GE Healthcare, Aspen Pharmacare Holdings Limited, Avet Pharmaceuticals, Inc., Par Pharmaceuticals, Teva Pharmaceuticals, Novartis AG, Heron Pharmaceutical, Inc., Piramal Enterprises Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample